Browse drugs

…and social care trust carcinoid heart disease pathwayConclusion NT-proBNP is a useful screening tool for the detection of CHD in patients…

…stract 1-029 Figure 1Correlation of maximal wall thickness with NT-pro BNP in patients with pathogenic gene mutations for hypertrophic car…

…sions in leads I, aVL, V5, V6). He was treated accordingly with aspirin, clopidogrel and morphine, and percutaneous coronary interventi…

…/L, and 16 (6%) >1000 ng/L ( figure 1). Of the 45 patients with NT-proBNP >400 ng/L, 41 underwent echocardiography. Among them, 16 (39%) …

…ng flow cytometry. HUVECs were exposed to known EndMT inducers, TGF-β2 (10 ng/mL) and IL-1β (10 ng/mL), for 6 days. Cultured HUVECs an…

… the cornerstone of treatment for advanced-stage disease. While lenvatinib has been a widely used first-line agent, the advent of immunoth…

…tcomes were analysed to indicate the treatment effectiveness of Rewind in military veterans.Results Significant improvement was found …

…erences observed between patients prescribed and not prescribed teduglutide. Qualitative analysis revealed that participants engaged in ite…

… at days 1, 2 and 3 after operation. A potential association of fetuin-A with the occurrence of AKI (at day 7 or discharge) or with chro…

…f the original trial (3.3 years), all participants were offered atorvastatin. Lipid profiles were obtained from all subjects 2 years later a…

… CIN II include large loop excision of the transformation zone, imiquimod and expectant management. Each treatment option has its drawbac…

…‘emergency donor panel’ (EDP) to obtain warm fresh whole blood (WFWB) which is then immediately transfused into the casualty. We des…